FDA & CDC Authorize COVID-19 Boosters for Eligible Individuals
Boosters have been approved for all 3 COVID-19 vaccines (Pfizer, Moderna and Johnson & Johnson).
Boosters for 12-15 year olds are authorized and available for online scheduling.
Schedule an appointment today.
The FDA and CDC have authorized COVID-19 boosters for Pfizer, Moderna and Johnson & Johnson recipients who meet the below criteria. See below for information on boosters as well as additional doses for moderately to severely immunocompromised individuals. What’s the difference between a booster and an additional dose?
Boosters can be administered at least 5 months after the 2nd dose of an initial series of Pfizer for individuals 12 years or older. Individuals 12-17 are only eligible for a Pfizer booster dose (no mixing and matching). Online scheduling for booster doses for individuals 12-15 coming soon.
Boosters can be administered at least 5 months after the 2nd dose of an initial series of Moderna or individuals 18 years or older. Moderna boosters will be administered at a half-dose volume compared to the initial series.
Johnson & Johnson/Janssen:
Boosters can be administered at least 2 months after the initial Johnson & Johnson/Janssen shot was administered for anyone age 18+. mRNA boosters (Pfizer or Moderna) are recommended over an additional dose of Johnson & Johnson/Janssen.
Can I choose a different vaccine for a booster (mix and match):
The CDC recommends a mRNA (Pfizer or Moderna) vaccine for your booster. Currently you can schedule a booster for the same vaccine you received for your initial series. If a different one is preferred, please talk to your pharmacist at the time of your appointment. Individuals 12-17 may only get a Pfizer booster.
Additional Doses for Immunocompromised
To meet the qualifications for an additional dose:
Individuals must have received the original series of either Pfizer or Moderna COVID-19 vaccine at least 28 days prior
AND be considered moderately to severely immunocompromised as defined below:
Had a solid organ transplant or recent hematopoietic malignancies
Active or recent treatment for solid tumor hematologic malignancies (cancer)
Severe primary immunodeficiency
Advanced or untreated HIV
Active treatment with high dose corticosteroids, alkylating agents, antimetabolites, TNF blockers, and other biologic agents
Asplenia and chronic renal disease can be considered if condition is severe
Additional doses can be administered to Pfizer recipients ages 5+ or Moderna recipients ages 18+. Online scheduling for 3rd doses for immunocompromised individuals 5-11 available now.
Moderately to severely immunocompromised individuals have been approved for a booster shot 5 months after a Pfizer 3rd dose for individuals ages 12+ or 5 months after a Moderna 3rd dose for individuals ages 18+.
For eligible individuals, please schedule an appointment today.